A1C Guidelines for Patients Over 60

Health Status-Based Targeting Algorithm

The American College of Physicians recommends targeting an A1C of 7-8% for most older adults to balance benefits against harms 1, 6
For healthy older adults with good functional status and life expectancy >10 years, the target A1C is <7% 4, 5
For patients with some comorbidities or established microvascular/macrovascular disease, the target A1C is 7-8% 1, 2, 6
For frail older adults, those with limited life expectancy (<5 years), or multiple comorbidities, the target A1C is 8-9% 4, 5, 3

Older adults ≥80 years are 5 times more likely to be hospitalized for insulin-related hypoglycemia compared to middle-aged adults 3
Targeting A1C <7% in very old or frail patients increases hypoglycemia risk without mortality benefit 3, 6
A1C levels <6.5% are associated with increased mortality and should prompt treatment de-escalation 1, 2

Measure A1C every 6 months if targets are not being met 4, 7
Every 12 months is acceptable for stable patients meeting individualized targets for several years 4, 7, 3

Do not use sulfonylureas or chlorpropamide in older adults due to prolonged hypoglycemia risk 3
Metformin is generally well-tolerated and low-cost, but still provides little benefit at A1C <7% 2

Do NOT apply uniform A1C targets across all older patients—this ignores critical individual differences in health status and life expectancy 1, 5, 2
Do NOT target A1C <6.5% with pharmacotherapy—this increases treatment burden and mortality without clinical benefit 1, 2

Focus on symptom management rather than specific A1C targets 2, 3
Treatment harms (hypoglycemia, polypharmacy burden, drug interactions) outweigh benefits in this population 4, 2

The American College of Physicians explicitly states that physician performance measures should NOT have A1C targets below 8% for any population and should have NO A1C targets for adults ≥80 years 1